Work

A randomized trial of consolidation-targeted adjuvant therapy with encorafenib and cetuximab versus usual care for patients with stage II/III BRAF V600E colon cancer: Alliance for Clinical Trials in Oncology A022004.

Year: 2023

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2023.41.16_suppl.tps3641

Authors: Rona Yaeger, Qian Shi, Amylou C. Dueck, Elie G. Dib, Syed Mohammad Ali Kazmi, Olatunji B. Alese, Smitha S. Krishnamurthi, Andrew B. Nixon, Ardaman Shergill, Eileen Mary O'Reilly, Jeffrey A Meyerhardt

Institutions: Memorial Sloan Kettering Cancer Center, Mayo Clinic, Trinity Health Ann Arbor Hospital, The University of Texas Southwestern Medical Center, Winship Cancer Institute, Cleveland Clinic, Duke Medical Center, University of Chicago, Dana-Farber Cancer Institute

Language: English

Topic: Colorectal Cancer Treatments and Studies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: National Institutes of Health

OpenAlex ID: W4379283381

Cites:

Cited by: 6

Related to: 10